drugset / Trial / NCT00128154

Chromium Picolinate for the Treatment of Metabolic Syndrome

NCT00128154

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether chromium supplements can reduce symptoms of metabolic syndrome, a collection of symptoms that increase one's risk for developing heart disease, stroke, and diabetes.

Timeline

Start
2004-01
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Chromium Picolinate Other / unclassified 1000 ug